ABIVAX Société Anonyme (EPA:ABVX)
France · Delayed Price · Currency is EUR 96.40
+2.80 (2.99%)
Apr 1, 2026, 9:43 AM CET
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of €7.41 billion as of March 31, 2026. Its market cap has increased by 1,795.22% in one year.
Market Cap
7.41B
Enterprise Value
6.91B
Revenue
4.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
€96.40
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from 202.12M to 7.41B, an increase of 3,566.95%. That is a compound annual growth rate of 39.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 7.03B | -24.96% |
| Dec 31, 2025 | 9.37B | 2,088.64% |
| Dec 31, 2024 | 428.15M | -30.40% |
| Dec 29, 2023 | 615.18M | 493.46% |
| Dec 30, 2022 | 103.66M | -77.81% |
| Dec 31, 2021 | 467.16M | -1.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.28B |
| DBV Technologies | 984.96M |
| Inventiva | 955.16M |
| MedinCell | 797.07M |
| Valneva SE | 479.91M |
| Genfit | 414.05M |
| Transgene | 205.37M |
| Cellectis | 203.98M |